Deng, Cuncan
Huo, Mingyu
Chu, Hongwu
Zhuang, Xiaomei
Deng, Guofei
Li, Wenchao
Wei, Hongfa
Zeng, Leli
He, Yulong
Liu, Huashan
Li, Jia
Zhang, Changhua
Chen, Hengxing
Funding for this research was provided by:
China Postdoctoral Science Foundation (2022M713588 and 2023M744016)
the National Natural Science Foundation of China (U20A20379, 82220108013, 82073148, 82200569 and 82102716, U20A20379, 82220108013, 82073148, 82200569 and 82102716, U20A20379, 82220108013, 82073148, 82200569 and 82102716, U20A20379, 82220108013, 82073148, 82200569 and 82102716)
Shenzhen Excellent Science and Technology Innovation Talent Training Project (RCBS20210706092410024 and JCYJ20220530144815035, RCBS20210706092410024 and JCYJ20220530144815035)
Guangdong Provincial Key Laboratory of Digestive Cancer Research (2021B1212040006)
Sanming Project of Medicine in Shenzhen (SZSM201911010, SZSM201911010)
Shenzhen Key Medical Discipline Construction Fund (SZXK016)
Article History
Received: 27 November 2023
Accepted: 22 February 2024
First Online: 8 March 2024
Declarations
:
: All animal studies were performed in compliance with Shenzhen TopBiotech Co., Ltd. (Shenzhen, China) institutional animal care regulations and conducted according to the AAALAC and the IACUC guidelines (No. SYSU-IACUC-2023-B0965). All human gastric cancer plasma and tissues were obtained with written informed consent from patients or their guardians prior to participation in our research. The sample collection procedure was approved by the Sun Yat-sen University Health Science Institution Review Board (No. KY-2022–051-02).
: The authors declare no competing interests.